The Committee for a Responsible Federal Budget released a detailed report on potential finance options for implementing "Medicare for All"; employers beginning to lessen dependence on high-deductible health plans; Juul to cut nearly 500 jobs by end of 2019.
Yesterday, the Committee for a Responsible Federal Budget (CRFB) released a paper providing estimates for potential ways to finance "Medicare for All," according to The Hill. The report stated that “policymakers have a number of options available to finance the $30 trillion cost of Medicare for All, but each option would come with its own set of tradeoffs.” The budget watchdog group said that most estimates related to implementing Medicare for All would cost the federal government about $30 trillion over 10 years, with several options, including a higher percent payroll tax, percent surtax on income above the standard-deduction amount, and a percent value-added tax, serving as possible financial tradeoffs.
Some employers are seeking traditional health plans alongside or instead of high-deductible health plans, which has served as the only option for some employees in the past few years, according to Kaiser Health News. Employers have cited the use of traditional health plans as an attractive recruitment tool that offers a deductible which does not unexpectedly turn out to be thousands in costs. The unpredictability of these out-of-pocket costs with high-deductible health plans has made these coverage options less appealing to employees, even if the premium in a traditional health plan is a bit higher.
E-cigarette manufacturer, Juul Labs, plans to cut nearly 500 jobs by the end of the year as part of an expansive reorganization plan aimed at repairing the company’s relationship with regulators. CNBC reports that Juul Labs will additionally cut its marketing budget and invest in ways to limit underage vaping, amid pressure from regulators and government agencies such as the FDA and CDC for its role in promoting its nicotine products to adolescents. The cuts will represent about 10% to 15% of Juul’s workforce, which currently employs about 4100 people.
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More